Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

CONMED (CNMD) Stock Trades Up, Here Is Why

July 13, 2026 at 13:00 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CNMD Cover Image

What Happened?

Shares of medical tech company CONMED (NYSE: CNMD) jumped 9% in the afternoon session after reports revealed the company is exploring a potential sale.

According to reports, the company is working with advisers to evaluate its options, including a sale, after receiving interest from private equity firms. The stock's move followed a significant jump in after-hours trading during the previous session when the news first broke. This suggests strong investor optimism about a potential deal.

Is now the time to buy CONMED? Access our full analysis report here, it’s free.

What Is The Market Telling Us

CONMED’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 14 days ago when the stock dropped 4.9% on the news that BofA Securities downgraded the stock to Underperform from Neutral, citing concerns about future growth.

The firm stated it expects CONMED to underperform other medical technology stocks over the next year. In its revised financial model, BofA lowered its 2027 organic growth estimate for the company to 4.5% from 5.8%. Furthermore, the firm reduced its 2027 earnings per share estimate to $4.54 from $4.67, placing it below the market consensus of $4.79. The price target for CONMED was maintained at $40.00.

CONMED is up 3.2% since the beginning of the year, but at $41.83 per share, it is still trading 25.1% below its 52-week high of $55.81 from August 2025. Despite the year-to-date gain, investors who bought $1,000 worth of CONMED’s shares 5 years ago would now be looking at only $314.80.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol

Price

Change (%)

AMZN

271.58

+36.08 (15.32%)

AAPL

308.91

-24.52 (-7.35%)

AMD

476.15

-9.24 (-1.90%)

BAC

61.95

+0.22 (0.36%)

GOOG

356.65

+22.97 (6.88%)